Plasma YKL-40, a new biomarker for atrial fibrillation?

YKL-40 Is Elevated in Patients with Chronic Obstructive Pulmonary Disease and Activates Alveolar Macrophages

(2014) S. Letuve et al.   JOURNAL OF IMMUNOLOGY

Serum levels of YKL-40 increases in patients with acute myocardial infarction

(2009) Camilla Nøjgaard et al.   CORONARY ARTERY DISEASE

Prognostic impact of hs‐CRP and IL‐6 in patients with persistent atrial fibrillation treated with electrical cardioversion

(2009) Kristoffer Mads Aaris Henningsen et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria

(2008) C. N. Rathcke et al.   DIABETES CARE

Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation

(2008) Vicente Climent et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease

(2008) Yongzhong Wang et al.   SCANDINAVIAN CARDIOVASCULAR JOURNAL

The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation

(2007) E M Kallergis et al.   HEART